CITATIONS:
1. Farmakis SG, Barnes AM, Carey JC, Braddock SR. Solid tumor screening
recommendations in trisomy 18. Am J Med Genet A .
2019;179(3):455-466. doi:10.1002/ajmg.a.61029
2. Silberberg A, Robetto J, Grimaux G, Nucifora L, Moreno Villares JM.
Ethical issues about the paradigm shift in the treatment of children
with trisomy 18. Eur J Pediatr . 2020;179(3):493-497.
doi:10.1007/s00431-019-03531-4
3. Goel N, Morris JK, Tucker D, et al. Trisomy 13 and 18-Prevalence and
mortality-A multi-registry population based analysis. Am J Med
Genet A . 2019;179(12):2382-2392. doi:10.1002/ajmg.a.61365
4. Lucas DJ, Rubinstein J, Gosain A, et al. Surgical and anesthetic
management for hepatectomy in two pediatric patients with trisomy 18,
pulmonary hypertension, and hepatoblastoma. Pediatr Blood Cancer .
2019;66(6):e27678. doi:10.1002/pbc.27678
5. Kalish JM, Doros L, Helman LJ, et al. Surveillance Recommendations
for Children with Overgrowth Syndromes and Predisposition to Wilms
Tumors and Hepatoblastoma. Clin Cancer Res Off J Am Assoc Cancer
Res . 2017;23(13):e115-e122. doi:10.1158/1078-0432.CCR-17-0710
6. Clericuzio CL, Chen E, McNeil DE, et al. Serum α-fetoprotein
screening for hepatoblastoma in children with Beckwith-Wiedemann
syndrome or isolated hemihyperplasia. J Pediatr .
2003;143(2):270-272. doi:10.1067/S0022-3476(03)00306-8
7. Zarate YA, Mena R, Martin LJ, Steele P, Tinkle BT, Hopkin RJ.
Experience with hemihyperplasia and Beckwith-Wiedemann syndrome
surveillance protocol. Am J Med Genet A . 2009;149A(8):1691-1697.
doi:10.1002/ajmg.a.32966
8. Children’s Oncology Group AHEP0731 Treatment of Children with All
Stages of
Hepatoblastoma with Temsirolimus (IND#122782, NSC#683664) Added to
High
Risk Stratum Treatment, A Phase III Study. Version Date: 11/07/18.
9. Janvier A, Farlow B, Wilfond BS. The Experience of Families With
Children With Trisomy 13 and 18 in Social Networks. Pediatrics .
2012;130(2):293-298. doi:10.1542/peds.2012-0151